Pharmaceutical Accountability Foundation

News from and about the Pharmaceutical Accountability Foundation

Recent News

“Six billion people have access to medicines today. So a lot has been achieved”

Wilbert Bannenberg, Chair of the Pharmaceutical Accountability Foundation, was interviewed by the Volkskrant on his life's work: promoting global equitable access to medicines. The article...

AbbVie tries to escape accountability for overcharging the Dutch healthcare system by 1.2 billion Euros

AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had abused...

The Pharmaceutical Accountability Foundation’s case against AbbVie: The Facts

Version 15 November 2023 About Adalimumab/Humira and pricing issues AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the best...

Answers to written Parliamentary questions by members Ellemeet and Westerveld (both Groenlinks) on the FtV lawsuit against AbbVie

Download the original (Dutch) here: antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload Download the English translation here: Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload

Subscribe to our newsletter

Never miss an update from the Pharmaceutical Accountability Foundation!

PAF in the News

Featured, 24 February, The British Medical Journal: Sharifah Sekalala, Katrina Perehudoff et al. An intersectional human rights approach toprioritising access to COVID-19 vaccines.


For Journalists

Interested in writing about our work? Please get in touch at

News by topic